Stay updated on Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedMinor wording updates were made to the Publications section and to the revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedA banner about government funding lapses and NIH operating status was removed from the page. The rest of the study details remain unchanged.SummaryDifference0.4%

- Check34 days agoChange DetectedNon-significant updates observed, including a newer last update timestamp and minor formatting changes. Core study details such as objectives, eligibility criteria, endpoints, and enrollment remain unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

- Check70 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.